- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07940673
Improving Advance Care Planning by Care Partners of Persons Living With Dementia Using a Narrative Video Game (ANTICIPATE)
The primary objective of this study is to evaluate the feasibility of using a narrative video game intervention to improve advance care planning (ACP) among care partners of people living with Alzheimer's Disease and Related Dementia. Feasibility will be assessed by evaluating acceptability as well as the fidelity of intervention delivery.
Studienübersicht
Status
Intervention / Behandlung
Detaillierte Beschreibung
The trial is designed to establish the feasibility and plausibility of using the intervention to alter psychological outcomes, necessary to justify a future Type 1 hybrid effectiveness-implementation trial.
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: Deepika Mohan, MD, MPH
- Telefonnummer: 412-647-0835
- E-Mail: mohand@upmc.edu
Studieren Sie die Kontaktsicherung
- Name: Caroline J Pidro
- Telefonnummer: 412-383-0821
- E-Mail: cjl13@pitt.edu
Studienorte
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, Vereinigte Staaten, 15213
- University of Pittsburgh
-
Kontakt:
- Deepika Mohan, MD, MPH
- Telefonnummer: 412-647-0835
- E-Mail: mohand@upmc.edu
-
Kontakt:
- Caroline J Pidro
- Telefonnummer: 412-383-0821
- E-Mail: cjl13@pitt.edu
-
Hauptermittler:
- Deepika Mohan, MD, MPH
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Be 18 years or older
- Identify as the primary support person (care partner) for health-related decisions for a person with dementia
Exclusion Criteria:
- the person with dementia has died
- the care partner does not have an email address
- the care partner is unwilling to be recorded
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Sonstiges
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Pre and Post Intervention (Narrative Video Game) Assessment
Participants in this arm will complete the Surrogate ACP Readiness Survey prior to intervention exposure. Participants will schedule a video-conference visit with the research facilitator. During the session, they will be asked to use the intervention (ANTICIPATE), a narrative video game that asks users to rehearse making an end-of-life medical decision for a fictional character. The experience takes 20-30 minutes to complete. Immediately following intervention exposure, participants will be asked to complete the User Engagement Survey, the Acceptability, Appropriateness, and Feasibility Measures, and the Surrogate ACP Readiness Survey. |
The intervention (ANTICIPATE) is a narrative video game that asks users to rehearse making an end-of-life medical decision for a fictional character. The game begins with an introduction to the main character (Glenn), then proceeds to demonstrating loss of function secondary to progression of dementia, then describes Glenn as experiencing a serious illness and requiring intubation or palliation. The player, who has taken on the role of Glenn's daughter, must consider her father's preferences and functional status as she decides how to proceed.
Andere Namen:
|
|
Experimental: Post-Intervention (Narrative Video Game) Assessment Only
Participants will schedule a video-conference visit with the research facilitator. During the session, they will be asked to use the intervention (ANTICIPATE), a narrative video game that asks users to rehearse making an end-of-life medical decision for a fictional character. The experience takes 20-30 minutes to complete. Immediately following intervention exposure, participants will be asked to complete the User Engagement Survey, the Acceptability, Appropriateness, and Feasibility Measures, and the Surrogate ACP Readiness Survey. |
The intervention (ANTICIPATE) is a narrative video game that asks users to rehearse making an end-of-life medical decision for a fictional character. The game begins with an introduction to the main character (Glenn), then proceeds to demonstrating loss of function secondary to progression of dementia, then describes Glenn as experiencing a serious illness and requiring intubation or palliation. The player, who has taken on the role of Glenn's daughter, must consider her father's preferences and functional status as she decides how to proceed.
Andere Namen:
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Acceptability of the intervention (co-primary)
Zeitfenster: Immediately following intervention exposure
|
Proportion of participants who score the intervention as ≥4/5 on the Acceptability of Intervention Measure |
Immediately following intervention exposure
|
|
Fidelity of intervention delivery (co-primary)
Zeitfenster: 3 months post-intervention exposure
|
Proportion of participants who complete all study tasks |
3 months post-intervention exposure
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Fidelity of intervention receipt
Zeitfenster: Pre-intervention to 3 months post-intervention
|
Mean responses to the items on the ACP Engagement Survey for Surrogate Decision makers and then summarized by domain (knowledge, readiness, self-efficacy, contemplation). |
Pre-intervention to 3 months post-intervention
|
|
Fidelity of intervention enactment (self-reported completion of ACP)
Zeitfenster: 3 months post-intervention
|
Proportion of participants who report ACP activities after intervention exposure |
3 months post-intervention
|
|
Fidelity of behavior change technique delivery
Zeitfenster: Immediately post-intervention
|
Proportion of participants who report the use of behavioral rehearsal during the game or who demonstrate the use of rehearsal during game play. |
Immediately post-intervention
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Amber Barnato, MD, MPH, MS, Dartmouth College
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- STUDY26060072
- R21AG098846 (US NIH Stipendium/Vertrag)
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
All collected and de-identified individual participant data.
IPD-Sharing-Zeitrahmen
It will be made available within 6 months of completion of the study, and will be available for 7 years.
IPD-Sharing-Zugriffskriterien
We will upload the data to a data repository (ICPSR), and researchers may access it by following the protocols set by the repository.
Art der unterstützenden IPD-Freigabeinformationen
- STUDIENPROTOKOLL
- SAFT
- ANALYTIC_CODE
- CSR
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .